[1] Chalkiadaki A, Guarente L. Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat Rev Endocrinol, 2012,8: 287-296.
[2] Yang T. Resveratrol, sirtuins, and viruses. Rev Med Virol, 2015.
[3] Lee YK, Moore DD. Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner. J Biol Chem, 2002, 277: 2463-2467.
[4] Chanda D, Xie YB, Choi HS. Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation. Nucleic Acids Res, 2010, 38: 4607-4619.
[5] Li X, Zhang S, Blander G, et al. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell, 2007,28: 91-106.
[6] Ma Y, Jiang LL, Shi RL, et al. [Effects of activation of liver X receptor and peroxisome proliferator-activated receptor alpha on bile acid synthesis in rats]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2007, 29: 384-387.
[7] Purushotham A, Xu Q, Lu J, et al. Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1alpha/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice. Mol Cell Biol, 2012, 32: 1226-1236.
[8] Kazgan N, Metukuri MR, Purushotham A, et al. Intestine-specific deletion of SIRT1 in mice impairs DCoH2-HNF-1alpha-FXR signaling and alters systemic bile acid homeostasis. Gastroenterology, 2014, 146: 1006-1016.
[9] Renga B, Migliorati M, Mencarelli A, et al. Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. Biochim Biophys Acta, 2009, 1792: 564-573.
[10] Chen F, Ma L, Sartor RB, et al. Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation. Gastroenterology, 2002, 123: 2005-2016.
[11] Green RM, Beier D, Gollan JL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology, 1996, 111: 193-198.
[12] Lam P, Soroka CJ, Boyer JL. The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease. Semin Liver Dis, 2010, 30: 125-133.
[13] Pauli-Magnus C, Lang T, Meier Y, et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics, 2004, 14: 91-102.
[14] Wang G, Amato S, Gilbert J, et al. Resveratrol up-regulates AMPA receptor expression via AMP-activated protein kinase-mediated protein translation. Neuropharmacology, 2015, 95: 144-153.
[15] Hussein MA. Prophylactic effect of resveratrol against ethinylestradiol-induced liver cholestasis. J Med Food, 2013, 16: 246-254.
[16] Lin TK, Huang LT, Huang YH, et al. The effect of the red wine polyphenol resveratrol on a rat model of biliary obstructed cholestasis: involvement of anti-apoptotic signalling, mitochondrial biogenesis and the induction of autophagy. Apoptosis, 2012, 17: 871-879.
[17] Xie HC, Han HP, Chen Z, et al. A study on the effect of resveratrol on lipid metabolism in hyperlipidemic mice. Afr J Tradit Complement Altern Med, 2014, 11:209-212.
[18] Chen Q, Wang E, Ma L, et al. Dietary resveratrol increases the expression of hepatic 7alpha-hydroxylase and ameliorates hyperch-olesterolemia in high-fat fed C57BL/6J mice. Lipids Health Dis, 2012,11:56.
[19] Castilla P, Echarri R, Dáralos A, et al. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr, 2006, 84: 252-262.
[20] Miyata M, Tozawa A, Otsuka H, et al. Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity. J Pharmacol Exp Ther, 2005,312: 759-766.
[21] Wang T, Zhou ZX, Sun LX, et al. Resveratrol effectively attenuates alpha-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms. Acta Pharmacol Sin, 2014, 35: 1527-1536.
[22] Chothe PP, Swaan PW. Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2). Biochem J, 2014,459: 301-312.
[23] Viatour P, Merville MP, Bours V, et al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci, 2005,30: 43-52.
[24] Chen LF, Mu Y, Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J, 2002,21: 6539-6548.
[25] Sharma M, Mohapatra J, Wagh A, et al. Involvement of TACE in colon inflammation: a novel mechanism of regulation via SIRT-1 activation. Cytokine, 2014,66: 30-39. |
